MAL18126011XPrescription (MAL-A)

DifflamAB Sore Throat Lozenges (Blackcurrant)

Generic Molecule: General Formulation

ACTIVE & APPROVEDValid till: 5 Dec 2028
NPRA Official Regulatory Summary

DifflamAB Sore Throat Lozenges (Blackcurrant) is a KKM-approved Prescription Medicine registered under MAL number MAL18126011X by iNova Pharmaceuticals (Singapore) Pte Ltd (incorporated In Singapore) Malaysia Branch. Its active ingredient is 2, 4-Dichlorophenylcarbinol 1.2 mg 2.5 g, Amylmetacresol 0.6 mg 2.5 g, manufactured by UNIQUE PHARMACEUTICAL LABORATORIES.

Holder (PRH)
iNova Pharmaceuticals (Singapore) Pte Ltd (incorporated In Singapore) Malaysia Branch
Manufacturer
UNIQUE PHARMACEUTICAL LABORATORIES
First Registered
5 Dec 2023
Validity
5 Dec 2028

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

3 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
2Formulation ProprietaryFind Brands
4-Dichlorophenylcarbinol1.2 mg 2.5 gFind Brands
Amylmetacresol0.6 mg 2.5 gFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL18126011X exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is DifflamAB Sore Throat Lozenges (Blackcurrant) approved by KKM / NPRA?

Yes. DifflamAB Sore Throat Lozenges (Blackcurrant) is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL18126011X with current status PRODUCT APPROVED. Registration was filed by iNova Pharmaceuticals (Singapore) Pte Ltd (incorporated In Singapore) Malaysia Branch.

What are the active ingredients of DifflamAB Sore Throat Lozenges (Blackcurrant)?

The declared active therapeutic components are: 2, 4-Dichlorophenylcarbinol 1.2 mg 2.5 g, Amylmetacresol 0.6 mg 2.5 g. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 35 registered brand formulations containing identical active ingredients (General Formulation). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: DifflamAB Sore Throat Lozenges (Blackcurrant) (MAL18126011X) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.